Frances Emms
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)MSD (UK) Limited (United Kingdom)(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Pharmacological Receptor Mechanisms and Effects, Neuroscience and Neuropharmacology Research, Neuropeptides and Animal Physiology
Most-Cited Works
- → 3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 Receptor(1996)257 cited
- → Expression and pharmacological characterization of the human D3 dopamine receptor.(1994)224 cited
- → Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor(1997)165 cited
- → 5-(4-Chlorophenyl)-4-methyl-3-(1-(2- phenylethyl)piperidin-4-yl)isoxazole: A Potent, Selective Antagonist at Human Cloned Dopamine D4 Receptors(1996)115 cited
- → Antagonism of the effects of (+)‐PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2receptor antagonist L‐741,626(1996)58 cited
- → Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells(1992)55 cited
- → 1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A Selective High-Affinity Antagonist for the Human Dopamine D4Receptor with Excellent Selectivity over Ion Channels(1999)53 cited
- → Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.(1996)49 cited
- → 4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D4 receptors(1999)48 cited
- → Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells(1993)48 cited